Camrese Lo extended-cycle and Cyclophosphamide Tablets
Determining the interaction of Camrese Lo extended-cycle and Cyclophosphamide Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Amethia, Amethia Lo, Camrese, Camrese Lo, Daysee, Introvale, Jolessa, LoSeasonique, Quartette, Quasense, Seasonale, Seasonique, Afirmelle, Altavera, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Chateal, Chateal EQ, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Rivelsa, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Preven EC, Triphasil
Synonyms: Camrese Lo (extended-cycle), Camrese Lo
Generic Name: cyclophosphamide
Brand name: Cytoxan, Neosar, Cytoxan Lyophilized
Synonyms: Cyclophosphamide (oral and injection), Cyclophosphamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camrese Lo extended-cycle-Cycloserine
- Camrese Lo extended-cycle-Cycloserine Capsules
- Camrese Lo extended-cycle-Cycloset
- Camrese Lo extended-cycle-Cyclosporine
- Camrese Lo extended-cycle-CycloSPORINE (Systemic)
- Camrese Lo extended-cycle-Cyclosporine Capsules
- Cyclophosphamide Tablets-Canagliflozin
- Cyclophosphamide Tablets-Canagliflozin and metformin
- Cyclophosphamide Tablets-Canagliflozin and Metformin Extended-Release Tablets
- Cyclophosphamide Tablets-Canagliflozin and Metformin Tablets
- Cyclophosphamide Tablets-Canakinumab
- Cyclophosphamide Tablets-Canakinumab Subcutaneous